Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 15207

1.

Polymorphism of R353Q (rs6046) in factor VII and the risk of myocardial infarction: A systematic review and meta-analysis.

Huang H, Long W, Zhao W, Zou L, Song Y, Zuo J, Yang Z.

Medicine (Baltimore). 2018 Sep;97(39):e12566. doi: 10.1097/MD.0000000000012566. Review.

2.

An update on the use of anticoagulant therapy in ST-segment elevation myocardial infarction.

van Gameren M, Lemmert ME, Wilschut JM, Daemen J, De Jaegere PPT, Zijlstra F, Van Mieghem NMDA, Diletti R.

Expert Opin Pharmacother. 2018 Sep;19(13):1441-1450. doi: 10.1080/14656566.2018.1512583. Epub 2018 Sep 5. Review.

PMID:
30185087
3.

Coronary CT Angiography and 5-Year Risk of Myocardial Infarction.

SCOT-HEART Investigators, Newby DE, Adamson PD, Berry C, Boon NA, Dweck MR, Flather M, Forbes J, Hunter A, Lewis S, MacLean S, Mills NL, Norrie J, Roditi G, Shah ASV, Timmis AD, van Beek EJR, Williams MC.

N Engl J Med. 2018 Sep 6;379(10):924-933. doi: 10.1056/NEJMoa1805971. Epub 2018 Aug 25.

PMID:
30145934
4.

Evaluating current and emerging antithrombotic therapy currently available for the treatment of acute coronary syndrome in geriatric populations.

Adamski P, Adamska U, Ostrowska M, Navarese EP, Kubica J.

Expert Opin Pharmacother. 2018 Sep;19(13):1415-1425. doi: 10.1080/14656566.2018.1510487. Epub 2018 Aug 22. Review.

PMID:
30132731
5.

Systematic assessment of decision-analytic models evaluating diagnostic tests for acute myocardial infarction based on cardiac troponin assays.

Veličković VM, Rochau U, Conrads-Frank A, Kee F, Blankenberg S, Siebert U.

Expert Rev Pharmacoecon Outcomes Res. 2018 Dec;18(6):619-640. doi: 10.1080/14737167.2018.1512857. Epub 2018 Sep 6. Review.

PMID:
30115001
6.

Association between IL-1β + 3954C/T polymorphism and myocardial infarction risk: A meta-analysis.

Fang Y, Xie H, Lin Z.

Medicine (Baltimore). 2018 Jul;97(30):e11645. doi: 10.1097/MD.0000000000011645. Review.

7.

Waist-hip ratio as a predictor of myocardial infarction risk: A systematic review and meta-analysis.

Cao Q, Yu S, Xiong W, Li Y, Li H, Li J, Li F.

Medicine (Baltimore). 2018 Jul;97(30):e11639. doi: 10.1097/MD.0000000000011639. Review.

8.

Effects of ambient temperature on myocardial infarction: A systematic review and meta-analysis.

Sun Z, Chen C, Xu D, Li T.

Environ Pollut. 2018 Oct;241:1106-1114. doi: 10.1016/j.envpol.2018.06.045. Epub 2018 Jun 19. Review.

PMID:
30029319
9.

The use of hemodynamics to predict mortality in patients undergoing primary PCI for ST-elevation myocardial infarction.

Goins AE, Rayson R, Yeung M, Stouffer GA.

Expert Rev Cardiovasc Ther. 2018 Aug;16(8):551-557. doi: 10.1080/14779072.2018.1497484. Epub 2018 Jul 13. Review.

PMID:
29975560
10.

Cardiovascular outcomes in patients who experienced a myocardial infarction while treated with liraglutide versus placebo in the LEADER trial.

Nauck MA, Tornøe K, Rasmussen S, Treppendahl MB, Marso SP; LEADER Publication Committee on behalf of the LEADER Trial Investigators.

Diab Vasc Dis Res. 2018 Sep;15(5):465-468. doi: 10.1177/1479164118783935. Epub 2018 Jun 27.

11.
12.

Acute right ventricular myocardial infarction.

Albulushi A, Giannopoulos A, Kafkas N, Dragasis S, Pavlides G, Chatzizisis YS.

Expert Rev Cardiovasc Ther. 2018 Jul;16(7):455-464. doi: 10.1080/14779072.2018.1489234. Epub 2018 Jun 27. Review.

PMID:
29902098
13.
14.

Electrocardiogram criteria of limb leads predicting right coronary artery as culprit artery in inferior wall myocardial infarction: A meta-analysis.

Liang H, Wu L, Li Y, Zeng Y, Hu Z, Li X, Sun X, Zhang Q, Zhou X.

Medicine (Baltimore). 2018 Jun;97(24):e10889. doi: 10.1097/MD.0000000000010889. Review.

15.

Plasma Circulating Extracellular RNAs in Left Ventricular Remodeling Post-Myocardial Infarction.

Danielson KM, Shah R, Yeri A, Liu X, Camacho Garcia F, Silverman M, Tanriverdi K, Das A, Xiao C, Jerosch-Herold M, Heydari B, Abbasi S, Van Keuren-Jensen K, Freedman JE, Wang YE, Rosenzweig A, Kwong RY, Das S.

EBioMedicine. 2018 Jun;32:172-181. doi: 10.1016/j.ebiom.2018.05.013. Epub 2018 May 18.

16.

Lactate in cardiogenic shock - current understanding and clinical implications.

Kubiak GM, Tomasik AR, Bartus K, Olszanecki R, Ceranowicz P.

J Physiol Pharmacol. 2018 Feb;69(1):15-21. doi: 10.26402/jpp.2018.1.02. Epub 2018 May 8. Review.

17.

Role of Cardiac Catheterization Lab Post Resuscitation in Patients with ST Elevation Myocardial Infarction.

Reddy S, Lee KS.

Curr Cardiol Rev. 2018;14(2):85-91. doi: 10.2174/1573403X14666180517080828. Review.

PMID:
29769006
18.

Problems in Stem Cell Therapy for Cardiac Repair and Tissue Engineering Approaches Based on Graphene and Its Derivatives.

Aslan A, Allahverdiyev AM, Bagirova M, Abamor ES.

Curr Stem Cell Res Ther. 2018;13(6):447-457. doi: 10.2174/1574888X13666180510110055. Review.

PMID:
29745340
19.

Mid-term outcomes of the Absorb BVS versus second-generation DES: A systematic review and meta-analysis.

Felix CM, van den Berg VJ, Hoeks SE, Fam JM, Lenzen M, Boersma E, Smits PC, Serruys PW, Onuma Y, van Geuns RJM.

PLoS One. 2018 May 9;13(5):e0197119. doi: 10.1371/journal.pone.0197119. eCollection 2018. Review.

20.

Practical Implications of Myocardial Viability Studies.

Ker WDS, Nunes THP, Nacif MS, Mesquita CT.

Arq Bras Cardiol. 2018 Mar;110(3):278-288. doi: 10.5935/abc.20180051. Review. Portuguese, English.

Supplemental Content

Loading ...
Support Center